Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201
Clinical trial NCT06078566 · TERMINATED
Trial details
- NCT number
- NCT06078566
- Sponsor
- Auregen Biotherapeutics, SA
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-26
- Primary completion
- 2025-11-14
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.